Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants.

Academic Article

Publication Date:

2007

Iris type:

01.01 Articolo in rivista

List of contributors:

Carlomagno, Francesca

Handle:

https://iris.cnr.it/handle/20.500.14243/51104

Published in:

CLINICAL CANCER RESEARCH (PRINT)

Journal